Interestingly, studies have shown that increased concentrations of glycine, about 10 times the normal plasma levels (~250 μM), inhibit angiogenesis and subsequent tumour growth, counteracting the effect of VEGF [52,53,54]. This evidence concerns the gene VEGFA and neoplasm.